BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31852924)

  • 21. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.
    Martins LJ; Bonczkowski P; Spivak AM; De Spiegelaere W; Novis CL; DePaula-Silva AB; Malatinkova E; Trypsteen W; Bosque A; Vanderkerckhove L; Planelles V
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):187-93. PubMed ID: 26171776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
    Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF
    J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attacking the HIV reservoir from the immune and viral perspective.
    Massanella M; Martinez-Picado J; Blanco J
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):33-41. PubMed ID: 23242702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
    Jung U; Takahashi M; Rossi JJ; Burnett JC
    Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
    Zhou Y; Zhang H; Siliciano JD; Siliciano RF
    J Virol; 2005 Feb; 79(4):2199-210. PubMed ID: 15681422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.
    Macedo AB; Resop RS; Martins LJ; Szaniawski MA; Sorensen ES; Spivak AM; Nixon DF; Jones RB; Planelles V; Bosque A
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):769-777. PubMed ID: 29926732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection.
    Soriano-Sarabia N; Archin NM; Bateson R; Dahl NP; Crooks AM; Kuruc JD; Garrido C; Margolis DM
    PLoS Pathog; 2015 Oct; 11(10):e1005201. PubMed ID: 26473478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
    PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers for HIV Cure: The Latent Reservoir.
    Castro-Gonzalez S; Colomer-Lluch M; Serra-Moreno R
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):739-759. PubMed ID: 30056745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4
    Sanyal A; Mailliard RB; Rinaldo CR; Ratner D; Ding M; Chen Y; Zerbato JM; Giacobbi NS; Venkatachari NJ; Patterson BK; Chargin A; Sluis-Cremer N; Gupta P
    Nat Med; 2017 Jul; 23(7):885-889. PubMed ID: 28553933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
    Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
    AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
    Stone M; Rosenbloom DIS; Bacchetti P; Deng X; Dimapasoc M; Keating S; Bakkour S; Richman DD; Mellors JW; Deeks SG; Lai J; Beg S; Siliciano JD; Pagliuzza A; Chomont N; Lackman-Smith C; Ptak RG; Busch MP
    J Infect Dis; 2021 Oct; 224(7):1209-1218. PubMed ID: 32147687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the single cycle replication of HIV-1 expressing Gaussia luciferase in human PBMCs, macrophages, and in CD4(+) T cell-grafted nude mouse.
    Ao Z; Huang J; Tan X; Wang X; Tian T; Zhang X; Ouyang Q; Yao X
    J Virol Methods; 2016 Feb; 228():95-102. PubMed ID: 26640121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
    Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays.
    Poon AFY; Prodger JL; Lynch BA; Lai J; Reynolds SJ; Kasule J; Capoferri AA; Lamers SL; Rodriguez CW; Bruno D; Porcella SF; Martens C; Quinn TC; Redd AD
    Retrovirology; 2018 Jul; 15(1):47. PubMed ID: 29976219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
    Yu J; Liang C; Liu SL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protection of Lymphocytes Against HIV using Lentivirus Vector Carrying a Combination of TRIM5α-HRH Genes and microRNA Against CCR5].
    Omelchenko DO; Glazkova DV; Bogoslovskaya EV; Urusov FA; Zhogina YA; Tsyganova GM; Shipulin GA
    Mol Biol (Mosk); 2018; 52(2):294-305. PubMed ID: 29695698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.